Long-term potentiation is increased in the CA1 area of the hippocampus of APPswe/ind CRND8 mice

Neurobiology of Disease

Volumn 11, Issue 3, 2002, Pages 394-409

  Jolas, Thierry ^a   Zhang, Xue Song ^a   Zhang, Qi ^a   Wong, Gwendolyn ^a   Del Vecchio, Robert ^a   Gold, Lisa ^a   Priestley, Tony ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; GENOTYPE; HIPPOCAMPUS; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; SYNAPSE; TRANSGENIC MOUSE;

EID: 0037004511     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0557     Document Type: Article

References (49)

1. Arias C., Arrieta I., Tapia R. Beta-amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. J. Neurosci. Res. 41:1995;561-566.
2. Arnold S. E. Part III. Neuropathology of Alzheimer's disease. Dis. Mon. 46:2000;687-705.
3. Banks M. I., White J. A., Pearce R. A. Interactions between distinct GABA(A) circuits in hippocampus. Neuron. 25:2000;449-457.
4. Chapman C. A., Perez Y., Lacaille J. C. Effects of GABA(A) inhibition on the expression of long-term potentiation in CA1 pyramidal cells are dependent on tetanization parameters. Hippocampus. 8:1998;289-298.
5. Chapman P. F., White G. L., Jones M. W., Cooper-Blacketer D., Marshall V. J., Irizarry M., Younkin L., Good M. A., Bliss T. V., Hyman B. T., Younkin S. G., Hsiao K. K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
6. Chen Q. S., Kagan B. L., Hirakura Y., Xie C. W. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J. Neurosci. Res. 60:2000;65-72.
7. Chishti M. A., Yang D. S., Janus C., Phinney A. L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P. E., Carlson G. A., George-Hyslop P., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276:2001;21562-21570.
8. Cullen W. K., Suh Y. H., Anwyl R., Rowan M. J. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. NeuroReport. 8:1997;3213-3217.
9. Davies C. H., Collingridge G. L. Regulation of EPSPs by the synaptic activation of GABAB autoreceptors in rat hippocampus. J. Physiol. 496:1996;451-470.
10. Davies C. H., Davies S. N., Collingridge G. L. Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. J. Physiol. 424:1990;513-531.
11. Dawson G. R., Seabrook G. R., Zheng H., Smith D. W., Graham S., O'Dowd G., Bowery B. J., Boyce S., Trumbauer M. E., Chen H. Y., Van der Ploeg L. H., Sirinathsinghji D. J. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience. 90:1999;1-13.
12. Fitzjohn S. M., Morton R. A., Kuenzi F., Davies C. H., Seabrook G. R., Collingridge G. L. Similar levels of long-term potentiation in amyloid precursor protein-null and wild-type mice in the CA1 region of picrotoxin treated slices. Neurosci. Lett. 288:2000;9-12.
13. Freir D. B., Holscher C., Herron C. E. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85:2001;708-713.
14. Furukawa K., Mattson M. P. Secreted amyloid precursor protein alpha selectively suppresses N-methyl-D-aspartate currents in hippocampal neurons: Involvement of cyclic GMP. Neuroscience. 83:1998;429-438.
15. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
16. Giacchino J., Criado J. R., Games D., Henriksen S. In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice. Brain Res. 876:2000;185-190.
17. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
18. Hauser W. A., Morris M. L., Heston L. L., Anderson V. E. Seizures and myoclonus in patients with Alzheimer's disease. Neurology. 36:1986;1226-1230.
19. Hesdorffer D. C., Hauser W. A., Annegers J. F., Kokmen E., Rocca W. A. Dementia and adult-onset unprovoked seizures. Neurology. 46:1996;727-730.
20. Hint H. C., Richter A. W. A simple intravenous infusion technique for mice: Method and some applications. Acta Pharmacol. Toxicol. 14:1958;153-157.
21. Hsia A. Y., Masliah E., McConlogue L., Yu G. Q., Tatsuno G., Hu K., Kholodenko D., Malenka R. C., Nicoll R. A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
22. Ishida A., Furukawa K., Keller J. N., Mattson M. P. Secreted form of beta-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. NeuroReport. 8:1997;2133-2137.
23. Itoh A., Akaike T., Sokabe M., Nitta A., Iida R., Olariu A., Yamada K., Nabeshima T. Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats. Eur. J. Pharmacol. 382:1999;167-175.
24. Janus C., Pearson J., McLaurin J., Mathews P. M., Jiang Y., Schmidt S. D., Chishti M. D., Horne P., Heslin D., French J., Mount H. T. J., Nixon R. A., Mercken M., Bergeron C., Fraser P. E., St. George-Hyslop P., Westaway D. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
25. Jeffery K. J. Paradoxical enhancement of long-term potentiation in poor-learning rats at low test stimulus intensities. Exp. Brain. Res. 104:1995;55-69.
26. Kim J. H., Anwyl R., Suh Y. H., Djamgoz M. B., Rowan M. J. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci. 21:2001;1327-1333.
27. A246E double transgenic mice. Neurobiol. Aging. 21:2000;563.
28. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840:1999;23-35.
29. Malenka R. C. Synaptic plasticity in the hippocampus: LTP and LTD. Cell. 78:1994;535-538.
30. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., Rydel R. E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron. 10:1993;243-254.
31. Morton R. A., Kuenzi F. M., Fitzjohn S. M. Normal synaptic plasticity in mice overexpressing a mutant form of human amyloid precursor protein. Neurobiol. Aging. 21:2000;1015.
32. Nguyen P. V., Abel T., Kandel E. R., Bourtchouladze R. Strain-dependent differences in LTP and hippocampus-dependent memory in inbred mice. Learn. Mem. 7:2000;170-179.
33. Noda M., Nakanishi H., Akaike N. Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience. 92:1999;1465-1474.
34. Pakaski M., Farkas Z., Kasa P. J., Forgon M., Papp H., Zarandi M., Penke B., Kasa P. S. Vulnerability of small GABAergic neurons to human beta-amyloid pentapeptide. Brain Res. 796:1998;239-246.
35. Parent A., Linden D. J., Sisodia S. S., Borchelt D. R. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6:1999;56-62.
36. Perez Y., Chapman C. A., Woodhall G., Robitaille R., Lacaille J. C. Differential induction of long-lasting potentiation of inhibitory postsynaptic potentials by theta patterned stimulation versus 100-Hz tetanization in hippocampal pyramidal cells in vitro. Neuroscience. 90:1999;747-757.
37. Romanelli M. F., Morris J. C., Ashkin K., Coben L. A. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch. Neurol. 47:1990;847-850.
38. Sawada M., Ichinose M. Amyloid beta proteins reduce the GABA-induced Cl-current in identified Aplysia neurons. Neurosci. Lett. 213:1996;213-215.
39. Schneider I., Reverse D., Dewachter I., Ris L., Caluwaerts N., Kuiperi C., Gilis M., Geerts H., Kretzschmar H., Godaux E., Moechars D., Van Leuven F., Herms J. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276:2001;11539-11544.
40. Seabrook G. R., Easter A., Dawson G. R., Bowery B. J. Modulation of long-term potentiation in CA1 region of mouse hippocampal brain slices by GABAA receptor benzodiazepine site ligands. Neuropharmacology. 36:1997;823-830.
41. Seabrook G. R., Rosahl T. W. Transgenic animals relevant to Alzheimer's disease. Neuropharmacology. 38:1999;1-17.
42. Seabrook G. R., Smith D. W., Bowery B. J., Easter A., Reynolds T., Fitzjohn S. M., Morton R. A., Zheng H., Dawson G. R., Sirinathsinghji D. J., Davies C. H., Collingridge G. L., Hill R. G. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology. 38:1999;349-359.
43. Selkoe D. J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann. NY Acad. Sci. 924:2000;17-25.
44. Shew T., Yip S., Sastry B. R. Mechanisms involved in tetanus-induced potentiation of fast IPSCs in rat hippocampal CA1 neurons. J. Neurophysiol. 83:2000;3388-3401.
45. Steele P. M., Mauk M. D. Inhibitory control of LTP and LTD: Stability of synapse strength. J. Neurophysiol. 81:1999;1559-1566.
46. Wu J., Anwyl R., Rowan M. J. Beta-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. NeuroReport. 6:1995a;2409-2413.
47. Wu J., Anwyl R., Rowan M. J. Beta-amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro. Eur. J. Pharmacol. 284:1995b;R1-R3.
48. Ye L., Qiao J. T. Suppressive action produced by beta-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: It's offset by (-)huperzine A. Neurosci. Lett. 275:1999;187-190.
49. Zaman S. H., Parent A., Laskey A., Lee M. K., Borchelt D. R., Sisodia S. S., Malinow R. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine. Neurobiol. Dis. 7:2000;54-63.